1. Home
  2. KW vs AMLX Comparison

KW vs AMLX Comparison

Compare KW & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennedy-Wilson Holdings Inc.

KW

Kennedy-Wilson Holdings Inc.

HOLD

Current Price

$9.84

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.97

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KW
AMLX
Founded
1977
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1992
2022

Fundamental Metrics

Financial Performance
Metric
KW
AMLX
Price
$9.84
$14.97
Analyst Decision
Sell
Strong Buy
Analyst Count
1
7
Target Price
$11.00
$17.43
AVG Volume (30 Days)
712.1K
1.8M
Earning Date
02-25-2026
03-03-2026
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$550,500,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$158.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.93
N/A
52 Week Low
$5.98
$2.60
52 Week High
$10.11
$17.49

Technical Indicators

Market Signals
Indicator
KW
AMLX
Relative Strength Index (RSI) 52.24 58.61
Support Level $9.71 $12.08
Resistance Level $10.09 $17.49
Average True Range (ATR) 0.18 1.02
MACD -0.02 0.38
Stochastic Oscillator 51.00 61.90

Price Performance

Historical Comparison
KW
AMLX

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: